Skip to main content
Journal cover image

Design of the efficacy of prednisone in the treatment of ocular myasthenia (EPITOME) trial.

Publication ,  Journal Article
Benatar, M; Sanders, DB; Wolfe, GI; McDermott, MP; Tawil, R
Published in: Ann N Y Acad Sci
December 2012

Efficacy of Prednisone in the Treatment of Ocular Myasthenia (EPITOME) is a multicenter, randomized, double blind, placebo-controlled trial that is being conducted under the auspices of the Muscle Study Group. EPITOME is the first randomized control trial in patients with ocular myasthenia and aims to evaluate the efficacy and tolerability of prednisone over a period of four months in patients with newly diagnosed ocular myasthenia whose symptoms have failed to remit in response to a trial of cholinesterase inhibitor therapy.

Duke Scholars

Published In

Ann N Y Acad Sci

DOI

EISSN

1749-6632

Publication Date

December 2012

Volume

1275

Start / End Page

17 / 22

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Prednisone
  • Placebos
  • Myasthenia Gravis
  • Humans
  • General Science & Technology
  • Eye Diseases
  • Double-Blind Method
  • Cholinesterase Inhibitors
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Benatar, M., Sanders, D. B., Wolfe, G. I., McDermott, M. P., & Tawil, R. (2012). Design of the efficacy of prednisone in the treatment of ocular myasthenia (EPITOME) trial. Ann N Y Acad Sci, 1275, 17–22. https://doi.org/10.1111/j.1749-6632.2012.06780.x
Benatar, Michael, Donald B. Sanders, Gil I. Wolfe, Michael P. McDermott, and Rabi Tawil. “Design of the efficacy of prednisone in the treatment of ocular myasthenia (EPITOME) trial.Ann N Y Acad Sci 1275 (December 2012): 17–22. https://doi.org/10.1111/j.1749-6632.2012.06780.x.
Benatar M, Sanders DB, Wolfe GI, McDermott MP, Tawil R. Design of the efficacy of prednisone in the treatment of ocular myasthenia (EPITOME) trial. Ann N Y Acad Sci. 2012 Dec;1275:17–22.
Benatar, Michael, et al. “Design of the efficacy of prednisone in the treatment of ocular myasthenia (EPITOME) trial.Ann N Y Acad Sci, vol. 1275, Dec. 2012, pp. 17–22. Pubmed, doi:10.1111/j.1749-6632.2012.06780.x.
Benatar M, Sanders DB, Wolfe GI, McDermott MP, Tawil R. Design of the efficacy of prednisone in the treatment of ocular myasthenia (EPITOME) trial. Ann N Y Acad Sci. 2012 Dec;1275:17–22.
Journal cover image

Published In

Ann N Y Acad Sci

DOI

EISSN

1749-6632

Publication Date

December 2012

Volume

1275

Start / End Page

17 / 22

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Prednisone
  • Placebos
  • Myasthenia Gravis
  • Humans
  • General Science & Technology
  • Eye Diseases
  • Double-Blind Method
  • Cholinesterase Inhibitors